mdlinx mdlinx

Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Journal of the National Cancer Institute, 04/20/2012

Timmers HJLM et al. – Compared with [123I]–metaiodobenzylguanidine single photon emission CT (123I–MIBG SPECT) and CT/magnetic resonance imaging (MRI), both considered gold standards for Pheochromocytomas and paragangliomas (PPGLs) imaging, metastases were better detected by 18F–fluorodeoxyglucose positron emission tomography with computed tomography (18F–FDG PET/CT). 18F–FDG PET provides a high specificity in patients with a biochemically established diagnosis of PPGL.

Read this article on Journal of the National Cancer Institute



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close